Companies in the Chinese healthcare industry, especially those in the business of producing and marketing ethical drugs and medical devises, face constant challenges in a complicated and rapid changing market environment. The China market for the industry is characterized by, among others, the following key factors:
•  Heavy government regulations and interventions that are not always easy to grasp and cope with
•  An under-developed and complex healthcare system further complicated by a largely rudimentary medical insurance market
•  Intense competition in fast growing yet still relatively modest market including increasing threat from generics
•  Downward price pressure may increase substantially if healthcare reform gains traction
•  Physicians overloaded and thus difficult to maintain relationship and get messages across
•  Patient-doctor relationship not entirely positive which hampers correct diagnosis, treatment and patient compliances

TNS Healthcare, an elite strategic research group is committed to help healthcare marketers in making better critical business decisions by providing fact-based consulting on a variety of issues such as:
•  Growth strategy formulation and evaluation
•  Market entry feasibility study
•  Marketing mix development
•  Effective product/brand positioning
•  Precise and effective physician targeting
•  Smart pricing strategy
•  Product/brand performance evaluation and diagnosis
•  Direct-to-consumer (DTC) strategy formulation and evaluation

Regardless how challenging your decision area is, TNS Healthcare can help you navigate the complicated China market by providing unbiased facts and solid strategic recommendations.